Optofluidic Bioassay, LLC SBIR Phase I Award, September 2022
A SBIR Phase I contract was awarded to Optofluidic Bioassay, LLC in September, 2022 for $256,131.0 USD from the U.S. Department of Health & Human Services and Centers for Disease Control and Prevention.
Name
# Contributions
Last Contribution
Find more entities like Optofluidic Bioassay, LLC SBIR Phase I Award, September 2022
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
